一个新的决策树,用于在卫生系统环境中对生物制剂进行风险评估
Zoe Ngo1, Scott Mayeda1, Stacey Yu2
1Investigational Drug Service, Stanford Health Care, Palo Alto, CA, USA.
概括
一个新的生物药物风险评估工具包含分子量来评估职业暴露风险. 这种决策树有助于重新分类危险药物,提高生物处理的安全性和效率.
科学领域:
- 职业健康 职业健康 职业健康
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 生物药物在医疗保健机构中越来越普遍.
- 现有的职业处理指南缺乏对生物制品的具体性.
- 国家职业安全与健康研究所 (NIOSH) 提供风险评估框架.
研究的目的:
- 开发和实施生物药物风险评估决策树.
- 通过包括分子性质参数来增强NIOSH风险评估程序.
- 改进对生物药物的职业暴露评估.
主要方法:
- 使用PubMed对与生物制剂,职业暴露和风险评估相关的关键词进行文献综述 (1991-2024年).
- 识别了通过皮肤,粘膜和吸入途径吸收的分子量切线.
- 开发了一个结合分子重量值的决策树.
主要成果:
- 确定了1000达尔顿的分子量值,在此以上,通过吸收途径的生物可用性是最小的.
- 实际应用导致89%以前危险的药物被重新分类.
- 在一个大型学术机构中展示了决策树的实用性.
结论:
- 开发了一种新的基于蛋白质的生物制品风险评估决策树,集成分子重量参数.
- 该工具标准化和简化了生物制剂的处理.
- 实施可以提高运营效率,同时确保员工的安全.
更多相关视频
07:35Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
7.4K
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
17.7K
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
101
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
101
Pharmacovigilance
732
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
732
Hazard Ratio
64
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
64
Analysis of Population Pharmacokinetic Data
190
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
190
Statistical Software for Data Analysis and Clinical Trials
279
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
279
Pharmacokinetic Models: Comparison and Selection Criterion
19
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
19
